Reduced experimental contact sensitivity in squamous cell but not basal cell carcinomas of skin

Berker, David de; Ibbotson, Sally H.; Simpson, N. B.; Rees, JL; Matthews, J. N. S.; Idle, J R

doi:10.1016/s0140-6736(95)90406-9

Cited by 16 publications

(10 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…40 In contrast to squamous cell carcinoma, the incidence of BCC is thought to be largely unaffected by the immune status. 41,42 However, our results suggest that at least IL6 is associated with BCC development.…”

Section: Discussioncontrasting

confidence: 54%

Case-control study in basal cell carcinoma of the skin: single nucleotide polymorphisms in three interleukin promoters pre-analysed in pooled DNA

Wilkening

Hemminki

Rudnai

et al. 2006

British Journal of Dermatology

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 54%

Case-control study in basal cell carcinoma of the skin: single nucleotide polymorphisms in three interleukin promoters pre-analysed in pooled DNA

Wilkening

Hemminki

Rudnai

et al. 2006

British Journal of Dermatology

View full text Add to dashboard Cite

show abstract

“…A diminished response to skin application of dinitrochlorobenzene was found in people with SCC but not in patients with BCC, again supporting the notion that the incidence of BCC is not affected by immune status. 148…”

Section: Immunological Factorsmentioning

confidence: 99%

Molecular aetiology and pathogenesis of basal cell carcinoma

et al. 2005

View full text Add to dashboard Cite

Summary Recent insights into the cell biology of the epidermis and its appendages are transforming our understanding of the pathogenesis of basal cell carcinoma (BCC). The significant progress that has been made warrants a comprehensive review of the molecular and cellular pathology of BCC. The items addressed include environmental and genetic risk factors, the biology of the putative precursor cell(s), and the contribution of aberrations in processes such as apoptosis, cell proliferation, differentiation and signalling to carcinogenesis. Furthermore, established and novel treatment modalities are discussed with particular attention to future biological approaches.

show abstract

“…An alteration in the immune status of the skin is thought to contribute to a number of common dermatological problems, including alopecia areata (AA), 1 viral warts 2 and some cutaneous tumours 3,4 . Extensive AA and resistant viral warts are notoriously difficult therapeutic problems; many patients obtain second and third opinions before abandoning hope of successful treatment.…”

mentioning

confidence: 99%

The therapeutic use of topical contact sensitizers in benign dermatoses

Buckley

Vivier

2008

British Journal of Dermatology

View full text Add to dashboard Cite

Topical therapy using contact sensitizers has been practised since the 1960s to treat conditions associated with an altered immunological state. Dinitrochlorobenzene, squaric acid dibutyl ester and diphencyprone are most commonly employed in the therapy of alopecia areata and viral warts. Few dermatology departments in the U.K. provide such treatment. This systematic review discusses the various contact sensitizers used for topical immunotherapy, the methodology of treatment, factors influencing efficacy and likely adverse effects.

show abstract

Reduced experimental contact sensitivity in squamous cell but not basal cell carcinomas of skin

Cited by 16 publications

References 8 publications

Case-control study in basal cell carcinoma of the skin: single nucleotide polymorphisms in three interleukin promoters pre-analysed in pooled DNA

Case-control study in basal cell carcinoma of the skin: single nucleotide polymorphisms in three interleukin promoters pre-analysed in pooled DNA

Molecular aetiology and pathogenesis of basal cell carcinoma

The therapeutic use of topical contact sensitizers in benign dermatoses

Contact Info

Product

Resources

About